Skip to content

Ultrasound Assessment of Stomach Contents Before Surgery in Patients Using Weight-Loss or Diabetes Medications

Assessment of Gastric Volume Using Preoperative Gastric Ultrasonography in Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0012167
Enrollment
300
Registered
2026-06-24
Start date
2026-06-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Adults aged 19 years or older. (2) Patients currently receiving GLP-1 receptor agonists (GLP-1 RAs). (3) Patients scheduled to undergo elective surgery under anesthesia.

Exclusion criteria

Exclusion criteria: (1) Hemodynamically unstable patients. (2) Pregnant or breastfeeding women. (3) Patients undergoing emergency surgery. (4) Patients unwilling or unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Residual gastric volume measured by gastric ultrasonography

Secondary

MeasureTime frame
Proportion of patients with high-risk gastric volume (=1.5 mL/kg);Fasting duration from the last solid meal to gastric ultrasonography.;Time interval from the last fluid intake to gastric ultrasonography;Incidence of pulmonary aspiration ;Incidence of postoperative nausea and vomiting;Total antiemetic consumption

Countries

Korea, Republic of

Contacts

Public ContactYu Jeong Bang

Samsung Medical Center

gagreflex.bang@gmail.com+82-2-1599-3114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 3, 2026